nodes	percent_of_prediction	percent_of_DWPC	metapath
Didanosine—SLC29A1—Fluorouracil—stomach cancer	0.548	0.919	CbGbCtD
Didanosine—SLC22A6—Methotrexate—stomach cancer	0.0483	0.081	CbGbCtD
Didanosine—PNP—Purine salvage—GMPR2—stomach cancer	0.0309	0.213	CbGpPWpGaD
Didanosine—PNP—Purine catabolism—NT5E—stomach cancer	0.0219	0.151	CbGpPWpGaD
Didanosine—PNP—Purine metabolism—GMPR2—stomach cancer	0.0147	0.101	CbGpPWpGaD
Didanosine—PNP—hematopoietic system—stomach cancer	0.00882	0.138	CbGeAlD
Didanosine—PNP—Purine metabolism—NT5E—stomach cancer	0.00843	0.058	CbGpPWpGaD
Didanosine—PNP—Nucleotide metabolism—GMPR2—stomach cancer	0.00737	0.0507	CbGpPWpGaD
Didanosine—PNP—lymphoid tissue—stomach cancer	0.00621	0.0972	CbGeAlD
Didanosine—PNP—digestive system—stomach cancer	0.00613	0.096	CbGeAlD
Didanosine—PNP—bone marrow—stomach cancer	0.00565	0.0885	CbGeAlD
Didanosine—PNP—endocrine gland—stomach cancer	0.00507	0.0793	CbGeAlD
Didanosine—PNP—liver—stomach cancer	0.00457	0.0715	CbGeAlD
Didanosine—PNP—Paclitaxel—Docetaxel—stomach cancer	0.00429	0.608	CbGdCrCtD
Didanosine—PNP—Nucleotide metabolism—NT5E—stomach cancer	0.00423	0.0291	CbGpPWpGaD
Didanosine—SLC29A1—Fluoropyrimidine Activity—XRCC3—stomach cancer	0.00422	0.0291	CbGpPWpGaD
Didanosine—SLC29A1—Fluoropyrimidine Activity—UMPS—stomach cancer	0.00405	0.0279	CbGpPWpGaD
Didanosine—PNP—Nucleotide metabolism—UMPS—stomach cancer	0.00387	0.0266	CbGpPWpGaD
Didanosine—SLC29A2—endocrine gland—stomach cancer	0.0038	0.0596	CbGeAlD
Didanosine—SLC29A1—Fluoropyrimidine Activity—TYMP—stomach cancer	0.00354	0.0244	CbGpPWpGaD
Didanosine—SLC29A2—liver—stomach cancer	0.00343	0.0537	CbGeAlD
Didanosine—PNP—Nucleotide metabolism—TYMP—stomach cancer	0.00338	0.0233	CbGpPWpGaD
Didanosine—SLC29A1—hematopoietic system—stomach cancer	0.00328	0.0514	CbGeAlD
Didanosine—SLC29A1—Fluoropyrimidine Activity—DPYD—stomach cancer	0.00281	0.0193	CbGpPWpGaD
Didanosine—PNP—Nucleotide metabolism—DPYD—stomach cancer	0.00268	0.0185	CbGpPWpGaD
Didanosine—SLC29A1—pancreas—stomach cancer	0.00267	0.0419	CbGeAlD
Didanosine—SLC29A2—lymph node—stomach cancer	0.00263	0.0412	CbGeAlD
Didanosine—SLC29A1—Fluoropyrimidine Activity—CYP2A6—stomach cancer	0.00245	0.0169	CbGpPWpGaD
Didanosine—SLC29A1—lymphoid tissue—stomach cancer	0.00231	0.0362	CbGeAlD
Didanosine—SLC29A1—digestive system—stomach cancer	0.00228	0.0358	CbGeAlD
Didanosine—SLC29A1—bone marrow—stomach cancer	0.0021	0.033	CbGeAlD
Didanosine—SLC29A1—endocrine gland—stomach cancer	0.00189	0.0295	CbGeAlD
Didanosine—SLC29A1—liver—stomach cancer	0.0017	0.0266	CbGeAlD
Didanosine—SLC29A1—Fluoropyrimidine Activity—TYMS—stomach cancer	0.0016	0.011	CbGpPWpGaD
Didanosine—PNP—Nucleotide metabolism—TYMS—stomach cancer	0.00153	0.0105	CbGpPWpGaD
Didanosine—SLC29A1—Fluoropyrimidine Activity—ERCC2—stomach cancer	0.00149	0.0102	CbGpPWpGaD
Didanosine—PNP—Daunorubicin—Epirubicin—stomach cancer	0.00144	0.204	CbGdCrCtD
Didanosine—SLC29A1—Fluoropyrimidine Activity—MTHFR—stomach cancer	0.0014	0.00961	CbGpPWpGaD
Didanosine—PNP—Daunorubicin—Doxorubicin—stomach cancer	0.00133	0.188	CbGdCrCtD
Didanosine—SLC29A2—Transport of vitamins, nucleosides, and related molecules—ALB—stomach cancer	0.00131	0.00903	CbGpPWpGaD
Didanosine—SLC29A1—lymph node—stomach cancer	0.0013	0.0204	CbGeAlD
Didanosine—SLC29A2—Transmembrane transport of small molecules—CLCN3—stomach cancer	0.00122	0.00837	CbGpPWpGaD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—SLC1A2—stomach cancer	0.00104	0.00717	CbGpPWpGaD
Didanosine—SLC29A1—Transport of vitamins, nucleosides, and related molecules—ALB—stomach cancer	0.00091	0.00626	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—CLCN3—stomach cancer	0.000843	0.0058	CbGpPWpGaD
Didanosine—PNP—Metabolism—ACAD8—stomach cancer	0.000751	0.00517	CbGpPWpGaD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—SLC1A2—stomach cancer	0.000722	0.00497	CbGpPWpGaD
Didanosine—PNP—Metabolism—GMPR2—stomach cancer	0.00067	0.00461	CbGpPWpGaD
Didanosine—PNP—Metabolism—IDH3B—stomach cancer	0.000612	0.00421	CbGpPWpGaD
Didanosine—PNP—Metabolism—SUCLG1—stomach cancer	0.000612	0.00421	CbGpPWpGaD
Didanosine—PNP—Metabolism—NDUFS1—stomach cancer	0.000569	0.00392	CbGpPWpGaD
Didanosine—PNP—Metabolism—NDUFV1—stomach cancer	0.000569	0.00392	CbGpPWpGaD
Didanosine—SLC29A1—Fluoropyrimidine Activity—TP53—stomach cancer	0.00053	0.00365	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—SLC1A2—stomach cancer	0.000529	0.00364	CbGpPWpGaD
Didanosine—Flatulence—Irinotecan—stomach cancer	0.000513	0.00274	CcSEcCtD
Didanosine—Dry eye—Epirubicin—stomach cancer	0.000513	0.00274	CcSEcCtD
Didanosine—PNP—Metabolism—BLVRB—stomach cancer	0.000508	0.00349	CbGpPWpGaD
Didanosine—PNP—Metabolism—PGLS—stomach cancer	0.000508	0.00349	CbGpPWpGaD
Didanosine—Alopecia—Fluorouracil—stomach cancer	0.000506	0.00271	CcSEcCtD
Didanosine—Diabetes mellitus—Methotrexate—stomach cancer	0.000495	0.00265	CcSEcCtD
Didanosine—PNP—Metabolism—PPAP2A—stomach cancer	0.000484	0.00333	CbGpPWpGaD
Didanosine—Neuropathy—Doxorubicin—stomach cancer	0.000482	0.00258	CcSEcCtD
Didanosine—Anaemia—Irinotecan—stomach cancer	0.000481	0.00257	CcSEcCtD
Didanosine—Hepatic failure—Methotrexate—stomach cancer	0.000479	0.00256	CcSEcCtD
Didanosine—Dry eye—Doxorubicin—stomach cancer	0.000475	0.00254	CcSEcCtD
Didanosine—Malaise—Irinotecan—stomach cancer	0.000469	0.00251	CcSEcCtD
Didanosine—Renal failure acute—Methotrexate—stomach cancer	0.000467	0.00249	CcSEcCtD
Didanosine—Leukopenia—Irinotecan—stomach cancer	0.000466	0.00249	CcSEcCtD
Didanosine—Diabetes mellitus—Epirubicin—stomach cancer	0.000463	0.00248	CcSEcCtD
Didanosine—Blood alkaline phosphatase increased—Epirubicin—stomach cancer	0.000463	0.00248	CcSEcCtD
Didanosine—Hepatic function abnormal—Epirubicin—stomach cancer	0.000461	0.00247	CcSEcCtD
Didanosine—Anaemia—Fluorouracil—stomach cancer	0.000461	0.00246	CcSEcCtD
Didanosine—Neuropathy peripheral—Docetaxel—stomach cancer	0.000451	0.00241	CcSEcCtD
Didanosine—Hyperglycaemia—Capecitabine—stomach cancer	0.000451	0.00241	CcSEcCtD
Didanosine—Hepatic failure—Epirubicin—stomach cancer	0.000449	0.0024	CcSEcCtD
Didanosine—Leukopenia—Fluorouracil—stomach cancer	0.000446	0.00239	CcSEcCtD
Didanosine—Anaphylactoid reaction—Methotrexate—stomach cancer	0.000445	0.00238	CcSEcCtD
Didanosine—Discomfort—Irinotecan—stomach cancer	0.000438	0.00234	CcSEcCtD
Didanosine—Neuropathy peripheral—Capecitabine—stomach cancer	0.000437	0.00234	CcSEcCtD
Didanosine—Renal failure acute—Epirubicin—stomach cancer	0.000437	0.00233	CcSEcCtD
Didanosine—Hepatobiliary disease—Docetaxel—stomach cancer	0.000436	0.00233	CcSEcCtD
Didanosine—PNP—Metabolism—NDUFA2—stomach cancer	0.000432	0.00297	CbGpPWpGaD
Didanosine—PNP—Metabolism—FBP1—stomach cancer	0.000432	0.00297	CbGpPWpGaD
Didanosine—PNP—Metabolism—CKB—stomach cancer	0.000432	0.00297	CbGpPWpGaD
Didanosine—PNP—Metabolism—CA1—stomach cancer	0.000432	0.00297	CbGpPWpGaD
Didanosine—Agranulocytosis—Docetaxel—stomach cancer	0.00043	0.0023	CcSEcCtD
Didanosine—Blood alkaline phosphatase increased—Doxorubicin—stomach cancer	0.000429	0.00229	CcSEcCtD
Didanosine—Diabetes mellitus—Doxorubicin—stomach cancer	0.000429	0.00229	CcSEcCtD
Didanosine—Hepatic function abnormal—Doxorubicin—stomach cancer	0.000427	0.00228	CcSEcCtD
Didanosine—Anaphylactic shock—Irinotecan—stomach cancer	0.000425	0.00227	CcSEcCtD
Didanosine—Myalgia—Fluorouracil—stomach cancer	0.000425	0.00227	CcSEcCtD
Didanosine—Renal impairment—Epirubicin—stomach cancer	0.000424	0.00226	CcSEcCtD
Didanosine—Infection—Irinotecan—stomach cancer	0.000422	0.00226	CcSEcCtD
Didanosine—Hepatobiliary disease—Capecitabine—stomach cancer	0.000422	0.00225	CcSEcCtD
Didanosine—Discomfort—Fluorouracil—stomach cancer	0.000419	0.00224	CcSEcCtD
Didanosine—Anaphylactoid reaction—Epirubicin—stomach cancer	0.000416	0.00223	CcSEcCtD
Didanosine—Agranulocytosis—Capecitabine—stomach cancer	0.000416	0.00223	CcSEcCtD
Didanosine—Thrombocytopenia—Irinotecan—stomach cancer	0.000416	0.00222	CcSEcCtD
Didanosine—Hepatic failure—Doxorubicin—stomach cancer	0.000415	0.00222	CcSEcCtD
Didanosine—Hepatitis—Docetaxel—stomach cancer	0.000413	0.00221	CcSEcCtD
Didanosine—Hypoglycaemia—Epirubicin—stomach cancer	0.000413	0.00221	CcSEcCtD
Didanosine—Hypoaesthesia—Docetaxel—stomach cancer	0.000411	0.0022	CcSEcCtD
Didanosine—Anaphylactic shock—Fluorouracil—stomach cancer	0.000407	0.00218	CcSEcCtD
Didanosine—PNP—Metabolism—PLIN2—stomach cancer	0.000406	0.00279	CbGpPWpGaD
Didanosine—Anorexia—Irinotecan—stomach cancer	0.000405	0.00217	CcSEcCtD
Didanosine—Infection—Fluorouracil—stomach cancer	0.000404	0.00216	CcSEcCtD
Didanosine—Renal failure acute—Doxorubicin—stomach cancer	0.000404	0.00216	CcSEcCtD
Didanosine—Hepatitis—Capecitabine—stomach cancer	0.0004	0.00214	CcSEcCtD
Didanosine—Thrombocytopenia—Fluorouracil—stomach cancer	0.000398	0.00213	CcSEcCtD
Didanosine—Hypoaesthesia—Capecitabine—stomach cancer	0.000398	0.00213	CcSEcCtD
Didanosine—PNP—Metabolism—CA2—stomach cancer	0.000395	0.00272	CbGpPWpGaD
Didanosine—Renal impairment—Doxorubicin—stomach cancer	0.000392	0.0021	CcSEcCtD
Didanosine—Anorexia—Fluorouracil—stomach cancer	0.000388	0.00207	CcSEcCtD
Didanosine—Anaphylactoid reaction—Doxorubicin—stomach cancer	0.000385	0.00206	CcSEcCtD
Didanosine—PNP—Metabolism—PGAM1—stomach cancer	0.000385	0.00265	CbGpPWpGaD
Didanosine—PNP—Metabolism—NT5E—stomach cancer	0.000385	0.00265	CbGpPWpGaD
Didanosine—Hypoglycaemia—Doxorubicin—stomach cancer	0.000382	0.00204	CcSEcCtD
Didanosine—Paraesthesia—Irinotecan—stomach cancer	0.000382	0.00204	CcSEcCtD
Didanosine—Dyspepsia—Irinotecan—stomach cancer	0.000374	0.002	CcSEcCtD
Didanosine—Chills—Docetaxel—stomach cancer	0.000371	0.00198	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000371	0.00198	CcSEcCtD
Didanosine—Decreased appetite—Irinotecan—stomach cancer	0.000369	0.00198	CcSEcCtD
Didanosine—Abdominal pain upper—Epirubicin—stomach cancer	0.000368	0.00197	CcSEcCtD
Didanosine—PNP—Metabolism—PLCE1—stomach cancer	0.000367	0.00253	CbGpPWpGaD
Didanosine—PNP—Metabolism—ALDH7A1—stomach cancer	0.000367	0.00253	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—SLC1A2—stomach cancer	0.000367	0.00252	CbGpPWpGaD
Didanosine—Paraesthesia—Fluorouracil—stomach cancer	0.000365	0.00195	CcSEcCtD
Didanosine—Alopecia—Docetaxel—stomach cancer	0.000365	0.00195	CcSEcCtD
Didanosine—Pancreatitis—Methotrexate—stomach cancer	0.000365	0.00195	CcSEcCtD
Didanosine—Pain—Irinotecan—stomach cancer	0.000363	0.00194	CcSEcCtD
Didanosine—Chills—Capecitabine—stomach cancer	0.000359	0.00192	CcSEcCtD
Didanosine—Dyspepsia—Fluorouracil—stomach cancer	0.000358	0.00192	CcSEcCtD
Didanosine—Decreased appetite—Fluorouracil—stomach cancer	0.000354	0.00189	CcSEcCtD
Didanosine—Alopecia—Capecitabine—stomach cancer	0.000354	0.00189	CcSEcCtD
Didanosine—PNP—Metabolism—UMPS—stomach cancer	0.000352	0.00242	CbGpPWpGaD
Didanosine—Pain—Fluorouracil—stomach cancer	0.000348	0.00186	CcSEcCtD
Didanosine—Gastrointestinal pain—Irinotecan—stomach cancer	0.000347	0.00186	CcSEcCtD
Didanosine—Flatulence—Capecitabine—stomach cancer	0.000343	0.00184	CcSEcCtD
Didanosine—Pancreatitis—Epirubicin—stomach cancer	0.000342	0.00183	CcSEcCtD
Didanosine—Abdominal pain upper—Doxorubicin—stomach cancer	0.000341	0.00182	CcSEcCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—CLCN3—stomach cancer	0.000337	0.00232	CbGpPWpGaD
Didanosine—Body temperature increased—Irinotecan—stomach cancer	0.000336	0.0018	CcSEcCtD
Didanosine—Abdominal pain—Irinotecan—stomach cancer	0.000336	0.0018	CcSEcCtD
Didanosine—Anaemia—Docetaxel—stomach cancer	0.000333	0.00178	CcSEcCtD
Didanosine—PNP—Metabolism—PDHA1—stomach cancer	0.000327	0.00225	CbGpPWpGaD
Didanosine—PNP—Metabolism—ECHS1—stomach cancer	0.000327	0.00225	CbGpPWpGaD
Didanosine—Leukopenia—Docetaxel—stomach cancer	0.000322	0.00172	CcSEcCtD
Didanosine—Anaemia—Capecitabine—stomach cancer	0.000322	0.00172	CcSEcCtD
Didanosine—Body temperature increased—Fluorouracil—stomach cancer	0.000322	0.00172	CcSEcCtD
Didanosine—Pancreatitis—Doxorubicin—stomach cancer	0.000316	0.00169	CcSEcCtD
Didanosine—Hyperglycaemia—Epirubicin—stomach cancer	0.000314	0.00168	CcSEcCtD
Didanosine—Malaise—Capecitabine—stomach cancer	0.000314	0.00168	CcSEcCtD
Didanosine—Hepatobiliary disease—Methotrexate—stomach cancer	0.000314	0.00168	CcSEcCtD
Didanosine—Hypersensitivity—Irinotecan—stomach cancer	0.000313	0.00167	CcSEcCtD
Didanosine—Leukopenia—Capecitabine—stomach cancer	0.000312	0.00167	CcSEcCtD
Didanosine—Agranulocytosis—Methotrexate—stomach cancer	0.00031	0.00166	CcSEcCtD
Didanosine—PNP—Metabolism—TYMP—stomach cancer	0.000307	0.00212	CbGpPWpGaD
Didanosine—PNP—Metabolism—FADS1—stomach cancer	0.000307	0.00212	CbGpPWpGaD
Didanosine—Myalgia—Docetaxel—stomach cancer	0.000306	0.00164	CcSEcCtD
Didanosine—Arthralgia—Docetaxel—stomach cancer	0.000306	0.00164	CcSEcCtD
Didanosine—Asthenia—Irinotecan—stomach cancer	0.000305	0.00163	CcSEcCtD
Didanosine—Neuropathy peripheral—Epirubicin—stomach cancer	0.000304	0.00163	CcSEcCtD
Didanosine—Hypersensitivity—Fluorouracil—stomach cancer	0.0003	0.0016	CcSEcCtD
Didanosine—Dry mouth—Docetaxel—stomach cancer	0.0003	0.0016	CcSEcCtD
Didanosine—Hepatitis—Methotrexate—stomach cancer	0.000298	0.00159	CcSEcCtD
Didanosine—Myalgia—Capecitabine—stomach cancer	0.000297	0.00159	CcSEcCtD
Didanosine—Arthralgia—Capecitabine—stomach cancer	0.000297	0.00159	CcSEcCtD
Didanosine—Hepatobiliary disease—Epirubicin—stomach cancer	0.000294	0.00157	CcSEcCtD
Didanosine—Anaphylactic shock—Docetaxel—stomach cancer	0.000294	0.00157	CcSEcCtD
Didanosine—Discomfort—Capecitabine—stomach cancer	0.000293	0.00157	CcSEcCtD
Didanosine—Infection—Docetaxel—stomach cancer	0.000292	0.00156	CcSEcCtD
Didanosine—Hyperglycaemia—Doxorubicin—stomach cancer	0.000291	0.00155	CcSEcCtD
Didanosine—Diarrhoea—Irinotecan—stomach cancer	0.000291	0.00155	CcSEcCtD
Didanosine—Dry mouth—Capecitabine—stomach cancer	0.00029	0.00155	CcSEcCtD
Didanosine—Agranulocytosis—Epirubicin—stomach cancer	0.00029	0.00155	CcSEcCtD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—SLC1A2—stomach cancer	0.000289	0.00199	CbGpPWpGaD
Didanosine—PNP—Metabolism—SREBF2—stomach cancer	0.000288	0.00198	CbGpPWpGaD
Didanosine—Pruritus—Fluorouracil—stomach cancer	0.000288	0.00154	CcSEcCtD
Didanosine—Thrombocytopenia—Docetaxel—stomach cancer	0.000288	0.00154	CcSEcCtD
Didanosine—PNP—Metabolism—RORA—stomach cancer	0.000285	0.00196	CbGpPWpGaD
Didanosine—Infection—Capecitabine—stomach cancer	0.000283	0.00151	CcSEcCtD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—ALB—stomach cancer	0.000282	0.00194	CbGpPWpGaD
Didanosine—Neuropathy peripheral—Doxorubicin—stomach cancer	0.000282	0.00151	CcSEcCtD
Didanosine—Anorexia—Docetaxel—stomach cancer	0.00028	0.0015	CcSEcCtD
Didanosine—Hepatitis—Epirubicin—stomach cancer	0.000279	0.00149	CcSEcCtD
Didanosine—Diarrhoea—Fluorouracil—stomach cancer	0.000278	0.00149	CcSEcCtD
Didanosine—Thrombocytopenia—Capecitabine—stomach cancer	0.000278	0.00149	CcSEcCtD
Didanosine—Hypoaesthesia—Epirubicin—stomach cancer	0.000277	0.00148	CcSEcCtD
Didanosine—Hepatobiliary disease—Doxorubicin—stomach cancer	0.000272	0.00145	CcSEcCtD
Didanosine—Anorexia—Capecitabine—stomach cancer	0.000271	0.00145	CcSEcCtD
Didanosine—Vomiting—Irinotecan—stomach cancer	0.00027	0.00144	CcSEcCtD
Didanosine—Agranulocytosis—Doxorubicin—stomach cancer	0.000268	0.00143	CcSEcCtD
Didanosine—Rash—Irinotecan—stomach cancer	0.000268	0.00143	CcSEcCtD
Didanosine—Dermatitis—Irinotecan—stomach cancer	0.000268	0.00143	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000268	0.00143	CcSEcCtD
Didanosine—Chills—Methotrexate—stomach cancer	0.000267	0.00143	CcSEcCtD
Didanosine—PNP—Metabolism—ALDOB—stomach cancer	0.000267	0.00183	CbGpPWpGaD
Didanosine—Headache—Irinotecan—stomach cancer	0.000266	0.00142	CcSEcCtD
Didanosine—Paraesthesia—Docetaxel—stomach cancer	0.000264	0.00141	CcSEcCtD
Didanosine—Alopecia—Methotrexate—stomach cancer	0.000263	0.00141	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000259	0.00139	CcSEcCtD
Didanosine—Vomiting—Fluorouracil—stomach cancer	0.000259	0.00138	CcSEcCtD
Didanosine—Dyspepsia—Docetaxel—stomach cancer	0.000259	0.00138	CcSEcCtD
Didanosine—Hepatitis—Doxorubicin—stomach cancer	0.000258	0.00138	CcSEcCtD
Didanosine—Hypoaesthesia—Doxorubicin—stomach cancer	0.000257	0.00137	CcSEcCtD
Didanosine—Rash—Fluorouracil—stomach cancer	0.000257	0.00137	CcSEcCtD
Didanosine—Dermatitis—Fluorouracil—stomach cancer	0.000256	0.00137	CcSEcCtD
Didanosine—Paraesthesia—Capecitabine—stomach cancer	0.000255	0.00137	CcSEcCtD
Didanosine—Decreased appetite—Docetaxel—stomach cancer	0.000255	0.00137	CcSEcCtD
Didanosine—Headache—Fluorouracil—stomach cancer	0.000255	0.00136	CcSEcCtD
Didanosine—Nausea—Irinotecan—stomach cancer	0.000252	0.00135	CcSEcCtD
Didanosine—Pain—Docetaxel—stomach cancer	0.000251	0.00134	CcSEcCtD
Didanosine—Dyspepsia—Capecitabine—stomach cancer	0.00025	0.00134	CcSEcCtD
Didanosine—Chills—Epirubicin—stomach cancer	0.00025	0.00134	CcSEcCtD
Didanosine—PNP—Metabolism—ALOX5—stomach cancer	0.000248	0.00171	CbGpPWpGaD
Didanosine—Decreased appetite—Capecitabine—stomach cancer	0.000247	0.00132	CcSEcCtD
Didanosine—Alopecia—Epirubicin—stomach cancer	0.000246	0.00132	CcSEcCtD
Didanosine—PNP—Metabolism—DPYD—stomach cancer	0.000244	0.00168	CbGpPWpGaD
Didanosine—Pain—Capecitabine—stomach cancer	0.000243	0.0013	CcSEcCtD
Didanosine—Nausea—Fluorouracil—stomach cancer	0.000242	0.00129	CcSEcCtD
Didanosine—Gastrointestinal pain—Docetaxel—stomach cancer	0.00024	0.00128	CcSEcCtD
Didanosine—Anaemia—Methotrexate—stomach cancer	0.00024	0.00128	CcSEcCtD
Didanosine—Flatulence—Epirubicin—stomach cancer	0.000239	0.00128	CcSEcCtD
Didanosine—SLC29A2—Transmembrane transport of small molecules—HMOX1—stomach cancer	0.000238	0.00164	CbGpPWpGaD
Didanosine—Malaise—Methotrexate—stomach cancer	0.000234	0.00125	CcSEcCtD
Didanosine—Gastrointestinal pain—Capecitabine—stomach cancer	0.000233	0.00124	CcSEcCtD
Didanosine—Body temperature increased—Docetaxel—stomach cancer	0.000232	0.00124	CcSEcCtD
Didanosine—Abdominal pain—Docetaxel—stomach cancer	0.000232	0.00124	CcSEcCtD
Didanosine—Leukopenia—Methotrexate—stomach cancer	0.000232	0.00124	CcSEcCtD
Didanosine—Chills—Doxorubicin—stomach cancer	0.000232	0.00124	CcSEcCtD
Didanosine—Alopecia—Doxorubicin—stomach cancer	0.000228	0.00122	CcSEcCtD
Didanosine—Abdominal pain—Capecitabine—stomach cancer	0.000225	0.0012	CcSEcCtD
Didanosine—Body temperature increased—Capecitabine—stomach cancer	0.000225	0.0012	CcSEcCtD
Didanosine—Anaemia—Epirubicin—stomach cancer	0.000224	0.0012	CcSEcCtD
Didanosine—Flatulence—Doxorubicin—stomach cancer	0.000221	0.00118	CcSEcCtD
Didanosine—Arthralgia—Methotrexate—stomach cancer	0.000221	0.00118	CcSEcCtD
Didanosine—Myalgia—Methotrexate—stomach cancer	0.000221	0.00118	CcSEcCtD
Didanosine—Malaise—Epirubicin—stomach cancer	0.000219	0.00117	CcSEcCtD
Didanosine—Discomfort—Methotrexate—stomach cancer	0.000218	0.00117	CcSEcCtD
Didanosine—Leukopenia—Epirubicin—stomach cancer	0.000217	0.00116	CcSEcCtD
Didanosine—Hypersensitivity—Docetaxel—stomach cancer	0.000216	0.00116	CcSEcCtD
Didanosine—PNP—Metabolism—GSTT1—stomach cancer	0.000216	0.00148	CbGpPWpGaD
Didanosine—PNP—Metabolism—CYP2A6—stomach cancer	0.000213	0.00147	CbGpPWpGaD
Didanosine—Anaphylactic shock—Methotrexate—stomach cancer	0.000212	0.00113	CcSEcCtD
Didanosine—Asthenia—Docetaxel—stomach cancer	0.000211	0.00113	CcSEcCtD
Didanosine—Infection—Methotrexate—stomach cancer	0.00021	0.00112	CcSEcCtD
Didanosine—Hypersensitivity—Capecitabine—stomach cancer	0.00021	0.00112	CcSEcCtD
Didanosine—Pruritus—Docetaxel—stomach cancer	0.000208	0.00111	CcSEcCtD
Didanosine—Anaemia—Doxorubicin—stomach cancer	0.000208	0.00111	CcSEcCtD
Didanosine—PNP—Metabolism—AKR1C3—stomach cancer	0.000207	0.00143	CbGpPWpGaD
Didanosine—Thrombocytopenia—Methotrexate—stomach cancer	0.000207	0.00111	CcSEcCtD
Didanosine—Arthralgia—Epirubicin—stomach cancer	0.000207	0.00111	CcSEcCtD
Didanosine—Myalgia—Epirubicin—stomach cancer	0.000207	0.00111	CcSEcCtD
Didanosine—Discomfort—Epirubicin—stomach cancer	0.000204	0.00109	CcSEcCtD
Didanosine—Asthenia—Capecitabine—stomach cancer	0.000204	0.00109	CcSEcCtD
Didanosine—Malaise—Doxorubicin—stomach cancer	0.000203	0.00108	CcSEcCtD
Didanosine—Dry mouth—Epirubicin—stomach cancer	0.000202	0.00108	CcSEcCtD
Didanosine—PNP—Metabolism—ENO1—stomach cancer	0.000202	0.00139	CbGpPWpGaD
Didanosine—Anorexia—Methotrexate—stomach cancer	0.000202	0.00108	CcSEcCtD
Didanosine—Pruritus—Capecitabine—stomach cancer	0.000201	0.00108	CcSEcCtD
Didanosine—Leukopenia—Doxorubicin—stomach cancer	0.000201	0.00108	CcSEcCtD
Didanosine—Diarrhoea—Docetaxel—stomach cancer	0.000201	0.00107	CcSEcCtD
Didanosine—Anaphylactic shock—Epirubicin—stomach cancer	0.000198	0.00106	CcSEcCtD
Didanosine—Infection—Epirubicin—stomach cancer	0.000197	0.00105	CcSEcCtD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—ALB—stomach cancer	0.000195	0.00134	CbGpPWpGaD
Didanosine—Diarrhoea—Capecitabine—stomach cancer	0.000195	0.00104	CcSEcCtD
Didanosine—Thrombocytopenia—Epirubicin—stomach cancer	0.000194	0.00104	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000193	0.00103	CcSEcCtD
Didanosine—Arthralgia—Doxorubicin—stomach cancer	0.000191	0.00102	CcSEcCtD
Didanosine—Myalgia—Doxorubicin—stomach cancer	0.000191	0.00102	CcSEcCtD
Didanosine—Paraesthesia—Methotrexate—stomach cancer	0.00019	0.00102	CcSEcCtD
Didanosine—Discomfort—Doxorubicin—stomach cancer	0.000189	0.00101	CcSEcCtD
Didanosine—Anorexia—Epirubicin—stomach cancer	0.000189	0.00101	CcSEcCtD
Didanosine—Dry mouth—Doxorubicin—stomach cancer	0.000187	0.001	CcSEcCtD
Didanosine—Vomiting—Docetaxel—stomach cancer	0.000187	0.000999	CcSEcCtD
Didanosine—Dyspepsia—Methotrexate—stomach cancer	0.000186	0.000996	CcSEcCtD
Didanosine—Rash—Docetaxel—stomach cancer	0.000185	0.00099	CcSEcCtD
Didanosine—Dermatitis—Docetaxel—stomach cancer	0.000185	0.000989	CcSEcCtD
Didanosine—Decreased appetite—Methotrexate—stomach cancer	0.000184	0.000984	CcSEcCtD
Didanosine—Headache—Docetaxel—stomach cancer	0.000184	0.000984	CcSEcCtD
Didanosine—Anaphylactic shock—Doxorubicin—stomach cancer	0.000183	0.00098	CcSEcCtD
Didanosine—Infection—Doxorubicin—stomach cancer	0.000182	0.000974	CcSEcCtD
Didanosine—Pain—Methotrexate—stomach cancer	0.000181	0.000968	CcSEcCtD
Didanosine—Vomiting—Capecitabine—stomach cancer	0.000181	0.000967	CcSEcCtD
Didanosine—SLC29A2—Transmembrane transport of small molecules—APOA1—stomach cancer	0.000181	0.00124	CbGpPWpGaD
Didanosine—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.00018	0.000965	CcSEcCtD
Didanosine—Thrombocytopenia—Doxorubicin—stomach cancer	0.000179	0.00096	CcSEcCtD
Didanosine—Rash—Capecitabine—stomach cancer	0.000179	0.000959	CcSEcCtD
Didanosine—PNP—Metabolism—CD44—stomach cancer	0.000179	0.00123	CbGpPWpGaD
Didanosine—Dermatitis—Capecitabine—stomach cancer	0.000179	0.000958	CcSEcCtD
Didanosine—Headache—Capecitabine—stomach cancer	0.000178	0.000953	CcSEcCtD
Didanosine—Paraesthesia—Epirubicin—stomach cancer	0.000178	0.000951	CcSEcCtD
Didanosine—Anorexia—Doxorubicin—stomach cancer	0.000175	0.000934	CcSEcCtD
Didanosine—Nausea—Docetaxel—stomach cancer	0.000174	0.000933	CcSEcCtD
Didanosine—Dyspepsia—Epirubicin—stomach cancer	0.000174	0.000933	CcSEcCtD
Didanosine—Gastrointestinal pain—Methotrexate—stomach cancer	0.000173	0.000926	CcSEcCtD
Didanosine—Decreased appetite—Epirubicin—stomach cancer	0.000172	0.000921	CcSEcCtD
Didanosine—Pain—Epirubicin—stomach cancer	0.000169	0.000906	CcSEcCtD
Didanosine—Nausea—Capecitabine—stomach cancer	0.000169	0.000903	CcSEcCtD
Didanosine—Abdominal pain—Methotrexate—stomach cancer	0.000167	0.000895	CcSEcCtD
Didanosine—Body temperature increased—Methotrexate—stomach cancer	0.000167	0.000895	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000167	0.000893	CcSEcCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—HMOX1—stomach cancer	0.000165	0.00114	CbGpPWpGaD
Didanosine—Paraesthesia—Doxorubicin—stomach cancer	0.000165	0.00088	CcSEcCtD
Didanosine—Gastrointestinal pain—Epirubicin—stomach cancer	0.000162	0.000866	CcSEcCtD
Didanosine—Dyspepsia—Doxorubicin—stomach cancer	0.000161	0.000863	CcSEcCtD
Didanosine—Decreased appetite—Doxorubicin—stomach cancer	0.000159	0.000852	CcSEcCtD
Didanosine—Pain—Doxorubicin—stomach cancer	0.000157	0.000838	CcSEcCtD
Didanosine—Body temperature increased—Epirubicin—stomach cancer	0.000157	0.000837	CcSEcCtD
Didanosine—Abdominal pain—Epirubicin—stomach cancer	0.000157	0.000837	CcSEcCtD
Didanosine—Hypersensitivity—Methotrexate—stomach cancer	0.000156	0.000834	CcSEcCtD
Didanosine—PNP—Metabolism—PPP2R1A—stomach cancer	0.000152	0.00105	CbGpPWpGaD
Didanosine—Asthenia—Methotrexate—stomach cancer	0.000152	0.000812	CcSEcCtD
Didanosine—Gastrointestinal pain—Doxorubicin—stomach cancer	0.00015	0.000802	CcSEcCtD
Didanosine—Pruritus—Methotrexate—stomach cancer	0.00015	0.000801	CcSEcCtD
Didanosine—PNP—Metabolism—GSTP1—stomach cancer	0.000149	0.00103	CbGpPWpGaD
Didanosine—PNP—Metabolism—HMOX1—stomach cancer	0.000147	0.00101	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—SLC1A2—stomach cancer	0.000147	0.00101	CbGpPWpGaD
Didanosine—Hypersensitivity—Epirubicin—stomach cancer	0.000146	0.000781	CcSEcCtD
Didanosine—Abdominal pain—Doxorubicin—stomach cancer	0.000145	0.000775	CcSEcCtD
Didanosine—Body temperature increased—Doxorubicin—stomach cancer	0.000145	0.000775	CcSEcCtD
Didanosine—Diarrhoea—Methotrexate—stomach cancer	0.000145	0.000775	CcSEcCtD
Didanosine—SLC29A2—Transmembrane transport of small molecules—ALB—stomach cancer	0.000143	0.000985	CbGpPWpGaD
Didanosine—Asthenia—Epirubicin—stomach cancer	0.000142	0.00076	CcSEcCtD
Didanosine—Pruritus—Epirubicin—stomach cancer	0.00014	0.00075	CcSEcCtD
Didanosine—PNP—Metabolism—TYMS—stomach cancer	0.000139	0.000956	CbGpPWpGaD
Didanosine—PNP—Metabolism—GSTM1—stomach cancer	0.000137	0.000945	CbGpPWpGaD
Didanosine—Diarrhoea—Epirubicin—stomach cancer	0.000136	0.000725	CcSEcCtD
Didanosine—Hypersensitivity—Doxorubicin—stomach cancer	0.000135	0.000722	CcSEcCtD
Didanosine—Vomiting—Methotrexate—stomach cancer	0.000135	0.00072	CcSEcCtD
Didanosine—Rash—Methotrexate—stomach cancer	0.000133	0.000714	CcSEcCtD
Didanosine—Dermatitis—Methotrexate—stomach cancer	0.000133	0.000713	CcSEcCtD
Didanosine—Headache—Methotrexate—stomach cancer	0.000133	0.000709	CcSEcCtD
Didanosine—Asthenia—Doxorubicin—stomach cancer	0.000132	0.000703	CcSEcCtD
Didanosine—Pruritus—Doxorubicin—stomach cancer	0.00013	0.000694	CcSEcCtD
Didanosine—PNP—Metabolism—ERCC2—stomach cancer	0.000129	0.000889	CbGpPWpGaD
Didanosine—Vomiting—Epirubicin—stomach cancer	0.000126	0.000674	CcSEcCtD
Didanosine—Nausea—Methotrexate—stomach cancer	0.000126	0.000672	CcSEcCtD
Didanosine—Diarrhoea—Doxorubicin—stomach cancer	0.000125	0.000671	CcSEcCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—APOA1—stomach cancer	0.000125	0.000862	CbGpPWpGaD
Didanosine—Rash—Epirubicin—stomach cancer	0.000125	0.000668	CcSEcCtD
Didanosine—Dermatitis—Epirubicin—stomach cancer	0.000125	0.000667	CcSEcCtD
Didanosine—Headache—Epirubicin—stomach cancer	0.000124	0.000664	CcSEcCtD
Didanosine—PNP—Metabolism—MTHFR—stomach cancer	0.000121	0.000835	CbGpPWpGaD
Didanosine—Nausea—Epirubicin—stomach cancer	0.000118	0.000629	CcSEcCtD
Didanosine—Vomiting—Doxorubicin—stomach cancer	0.000117	0.000623	CcSEcCtD
Didanosine—Rash—Doxorubicin—stomach cancer	0.000116	0.000618	CcSEcCtD
Didanosine—Dermatitis—Doxorubicin—stomach cancer	0.000115	0.000617	CcSEcCtD
Didanosine—Headache—Doxorubicin—stomach cancer	0.000115	0.000614	CcSEcCtD
Didanosine—PNP—Metabolism—CAV1—stomach cancer	0.000112	0.00077	CbGpPWpGaD
Didanosine—PNP—Metabolism—APOA1—stomach cancer	0.000112	0.000769	CbGpPWpGaD
Didanosine—Nausea—Doxorubicin—stomach cancer	0.000109	0.000582	CcSEcCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—ALB—stomach cancer	9.93e-05	0.000683	CbGpPWpGaD
Didanosine—PNP—Metabolism—PPARG—stomach cancer	9.84e-05	0.000677	CbGpPWpGaD
Didanosine—PNP—Metabolism—ALB—stomach cancer	8.85e-05	0.000609	CbGpPWpGaD
Didanosine—PNP—Metabolism—NOS3—stomach cancer	8.47e-05	0.000583	CbGpPWpGaD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—ALB—stomach cancer	7.81e-05	0.000537	CbGpPWpGaD
Didanosine—PNP—Metabolism—PTGS2—stomach cancer	7.74e-05	0.000533	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—HMOX1—stomach cancer	6.61e-05	0.000455	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—APOA1—stomach cancer	5.01e-05	0.000345	CbGpPWpGaD
Didanosine—PNP—Metabolism—PIK3CA—stomach cancer	4.76e-05	0.000328	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—ALB—stomach cancer	3.97e-05	0.000273	CbGpPWpGaD
